NSAID-induced polyp regression in familial adenomatous polyposis patients

Research output: Contribution to journalArticlepeer-review

Abstract

NSAIDs inhibit prostaglandin synthesis. In 1983, Waddell et al first reported that sulindac, a NSAID (Clinoril), caused regression of rectal adenomatous polyps in several patients with familial adenomatous polyposis, an inherited form of colorectal cancer. Subsequently, NSAIDs have been used as chemopreventive agents in animal carcinogenesis models and adenoma regression has been confirmed in human trials with sulindac. This article summarizes these developments and describes possible mechanisms of colorectal neoplasia chemoprevention.

Original languageEnglish (US)
Pages (from-to)349-361
Number of pages13
JournalGastroenterology Clinics of North America
Volume25
Issue number2
DOIs
StatePublished - Jan 1 1996

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'NSAID-induced polyp regression in familial adenomatous polyposis patients'. Together they form a unique fingerprint.

Cite this